Long-Term Prognosis and Risk Heterogeneity of Heart Failure Complicating Acute Myocardial Infarction

American Journal of Cardiology

Volumn 115, Issue 7, 2015, Pages 872-878

  de Carvalho, Leonardo P ^a,b   Gao, Fei ^c,d   Chen, Qifeng ^c   Sim, Ling Ling ^c   Koh, Tian Hai ^c   Foo, David ^e   Ong, Hean Yee ^f   Tong, Khim Leng ^g   Tan, Huay Cheem ^a   Yeo, Tiong Cheng ^a   Chow, Khuan Yew ^h   Richards, A Mark ^a   Peterson, Eric D ⁱ   Chua, Terrance ^c   Chan, Mark Y ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c DEPARTMENT OF CARDIOLOGY   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e TAN TOCK SENG HOSPITAL   (Singapore)

^f KHOO TECK PUAT HOSPITAL   (Singapore)

^g CHANGI GENERAL HOSPITAL   (Singapore)

^h National Registry of Diseases Office   (Singapore)

ⁱ DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ADULT; AGE; AGED; ARTICLE; BRAIN HYPOXIA; CARDIOVASCULAR MORTALITY; COMPLETE HEART BLOCK; DISEASE CLASSIFICATION; ETHNICITY; FEMALE; GENDER; HEART RUPTURE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE SEPTUM RUPTURE; HUMAN; INTRAAORTIC BALLOON PUMP; KILLIP CLASSIFICATION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY RATE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CAUSE OF DEATH; CLINICAL TRIAL; COMPLICATION; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART FAILURE; INCIDENCE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINGAPORE; SURVIVAL RATE; TIME; TRENDS;

AGED; CAUSE OF DEATH; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SINGAPORE; SURVIVAL RATE; TIME FACTORS;

EID: 84929507095     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.01.010     Document Type: Article

References (22)

1. 1 Killip, T. III, Kimball, J.T., Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20 (1967), 457–464.
2. 2 Rott, D., Behar, S., Gottlieb, S., Boyko, V., Hod, H., Usefulness of the Killip classification for early risk stratification of patients with acute myocardial infarction in the 1990s compared with those treated in the 1980s. Israeli Thrombolytic Survey Group and the Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Am J Cardiol 80 (1997), 859–864.
3. 3 El-Menyar, A., Zubaid, M., AlMahmeed, W., Sulaiman, K., AlNabti, A., Singh, R., Al Suwaidi, J., Killip classification in patients with acute coronary syndrome: insight from a multicenter registry. Am J Emerg Med 30 (2012), 97–103.
4. 4 Madias, J.E., Killip and Forrester classifications: should they be abandoned, kept, reevaluated, or modified?. Chest 117 (2000), 1223–1226.
5. 5 Bongard, V., Puel, J., Savary, D., Belle, L., Charpentier, S., Cottin, Y., Soulat, L., Elbaz, M., Miljkovic, D., Steg, P.G., OPTIMAL Investigators. Predictors of infarct artery patency after prehospital thrombolysis: the multicentre, prospective, observational OPTIMAL study. Heart 95 (2009), 799–806.
6. 6 DeGeare, V.S., Boura, J.A., Grines, L.L., O'Neill, W.W., Grines, C.L., Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 87 (2001), 1035–1038.
7. 7 Hanania, G., Cambou, J.P., Gueret, P., Vaur, L., Blanchard, D., Lablanche, J.M., Boutalbi, Y., Humbert, R., Clerson, P., Genes, N., Danchin, N., USIC 2000 Investigators. Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry. Heart 90 (2004), 1404–1410.
8. 8 Steg, P.G., Dabbous, O.H., Feldman, L.J., Cohen-Solal, A., Aumont, M.C., Lopez-Sendon, J., Budaj, A., Goldberg, R.J., Klein, W., Anderson, F.A. Jr., Global Registry of Acute Coronary Events Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 109 (2004), 494–499.
9. 9 Khot, U.N., Jia, G., Moliterno, D.J., Lincoff, A.M., Khot, M.B., Harrington, R.A., Topol, E.J., Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA 290 (2003), 2174–2181.
10. 10 Hochman, J.S., Buller, C.E., Sleeper, L.A., Boland, J., Dzavik, V., Sanborn, T.A., Godfrey, E., White, H.D., Lim, J., LeJemtel, T., Cardiogenic shock complicating acute myocardial infarction–etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol 36 (2000), 1063–1070.
11. 11 Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.M., Pajak, A., Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90 (1994), 583–612.
12. 12 Chan, M.Y., Shah, B.R., Gao, F., Sim, L.L., Chua, T., Tan, H.C., Yeo, T.C., Ong, H.Y., Foo, D., Goh, P.P., Surrun, S.K., Pieper, K.S., Granger, C.B., Koh, T.H., Salim, A., Tai, E.S., Recalibration of the Global Registry of Acute Coronary Events risk score in a multiethnic Asian population. Am Heart J 162 (2011), 291–299.
13. 13 Alpert, J.S., Thygesen, K., Antman, E., Bassand, J.P., Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000), 959–969.
14. 14 Chan, M.Y., Sun, J.L., Newby, L.K., Shaw, L.K., Lin, M., Peterson, E.D., Califf, R.M., Kong, D.F., Roe, M.T., Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation 119 (2009), 3110–3117.
15. 15 Dale, O., Salo, M., The Helsinki Declaration, research guidelines and regulations: present and future editorial aspects. Acta Anaesthesiol Scand 40 (1996), 771–772.
16. 16 Fox, K.A., Dabbous, O.H., Goldberg, R.J., Pieper, K.S., Eagle, K.A., Van de Werf, F., Avezum, A., Goodman, S.G., Flather, M.D., Anderson, F.A. Jr., Granger, C.B., Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ, 333, 2006, 1091.
17. 17 Franco, E., Nunez-Gil, I.J., Vivas, D., Ruiz Mateos, B., Ibanez, B., Gonzalo, N., Macaya, C., Fernandez Ortiz, A., Heart failure and non-ST-segment elevation myocardial infarction: a review for a widespread situation. Eur J Int Med 22 (2011), 533–540.
18. 18 Nunez-Gil, I.J., Garcia-Rubira, J.C., Luaces, M., Vivas, D., De Agustin, J.A., Gonzalez-Ferrer, J.J., Bordes, S., Macaya, C., Fernandez-Ortiz, A., Mild heart failure is a mortality marker after a non-ST-segment acute myocardial infarction. Eur J Int Med 21 (2010), 439–443.
19. 19 Reynolds, H.R., Hochman, J.S., Cardiogenic shock: current concepts and improving outcomes. Circulation 117 (2008), 686–697.
20. 20 Singh, M., White, J., Hasdai, D., Hodgson, P.K., Berger, P.B., Topol, E.J., Califf, R.M., Holmes, D.R. Jr., Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial. J Am Coll Cardiol 50 (2007), 1752–1758.
21. 21 Ketchum, E.S., Dickstein, K., Kjekshus, J., Pitt, B., Wong, M.F., Linker, D.T., Levy, W.C., The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunction. Eur Heart J Acute Cardiovasc Care 3 (2014), 46–55.
22. 22 Chen, Z.M., Pan, H.C., Chen, Y.P., Peto, R., Collins, R., Jiang, L.X., Xie, J.X., Liu, L.S., COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005), 1622–1632.